Genitourinary Cancer Program

The genitourinary cancer program focuses on the urinary and male genital tracts. Genitourinary cancer may involve the prostate, bladder, kidney, testes, or penis. Gibbs Cancer Center & Research Institute, in collaboration with urologists, offers services to assess your genitourinary cancer risk, screen for certain genitourinary cancers, and when diagnosed with a genitourinary cancer navigate you through treatment and survivorship.

Our highly specialized team of experts collaborates to offer you the latest treatment advances. Options may include:  minimally invasive surgical procedures, such as robot assisted prostatectomy; radiation therapy-external beam and prostate brachytherapy (both permanent seed implants and high-dose-rate brachytherapy are offered); hormonal therapy; and targeted chemotherapy. Additionally, every patient is reviewed for possible participation in a clinical trial.  Your treatments options are discussed during the Genitourinary Multidisciplinary Planning Conference. This is where treatment options are personalized for you.